Liddle's syndrome

Liddle syndrome is a rare genetic disorder characterized by early-onset hypertension, hypokalemia, and metabolic alkalosis. The pathogenesis of the disease is due to mutations in the genes encoding epithelial sodium channels (ENaC), which leads to excessive sodium reabsorption in the distal nephron and increased sensitivity to mineralocorticoids. First described in the mid-20th century, the disease remains a diagnostic challenge for clinicians.

History of the disease and interesting historical facts

This pathology was first described by American pediatrician Gordon Liddle in 1964 while studying a family case of hypertension. Interestingly, the disease was initially misdiagnosed as Conn's syndrome, but further studies revealed a unique mechanism for the development of hypertension. In 1994, a group of scientists led by Lifton RP established the exact genetic nature of the disease. "This discovery was an important step in understanding the mechanisms of blood pressure regulation," said Stanford University professor David Fletcher.

Epidemiology

Liddle syndrome is an extremely rare disease, with an incidence of less than 1 case per million population. According to the International Registry of Rare Kidney Diseases, most cases are registered in countries with a developed neonatal screening system. The disease occurs equally often in men and women, with the first symptoms usually appearing between the ages of 1 and 3 years.

Genetic predisposition to this disease

The disease is inherited in an autosomal dominant manner and is associated with mutations in the SCNN1B or SCNN1G genes, encoding the β- and γ-subunits of the epithelial sodium channel, respectively. The most common mutations are:

• Missense mutation R566X in the SCNN1B gene
• Frameshift mutation in exon 13 of the SCNN1G gene
• Nonsense mutation Q589X in the SCNN1B gene

These mutations result in the loss of the ENaC degradation mechanism, causing its persistent activation.

Risk factors for the development of this disease

Risk factors include:

• Presence of similar cases in the family
• Consanguine marriages
• Exposure to teratogenic factors during pregnancy
• Certain medications that affect electrolyte balance

Diagnosis of this disease

The main diagnostic criteria include:

• Early development of severe arterial hypertension
• Hypokalemia (<3.0 mmol/L)
• Metabolic alkalosis
• Normal renin and aldosterone levels

Additional research methods:

• Genetic analysis
• Test with amiloride
• Electrocardiography
• Ultrasound of the kidneys

Treatment

The basis of treatment is pharmacological therapy aimed at blocking ENaC. Surgical intervention is indicated only in the event of complications. Correction of electrolyte disturbances and constant blood pressure monitoring are of great importance.

List of drugs used to treat this disease

• Amiloride
• Triamterene
• Spironolactone (in combination therapy)

Disease monitoring

Patients require regular monitoring every 3-6 months with control of:

• Potassium and sodium levels in the blood
• HELL
• Functions of the kidneys
• ECG

The prognosis with adequate therapy is favorable, but complications such as stroke, myocardial infarction and chronic kidney disease are possible.

Age-related features of the disease

In childhood, the disease is more severe, often accompanied by growth retardation. In adult patients, left ventricular hypertrophy and other complications of hypertension are more common.

Questions and Answers

• How to differentiate Liddle syndrome from other forms of hypertension? The main difference is the normal level of renin and aldosterone in the presence of severe hypertension.
• Is it possible to cure this disease completely? A complete cure is impossible, but modern therapy allows for effective control of symptoms.
• What is the role of genetic testing? Genetic analysis is the gold standard for diagnosis and can confirm the diagnosis.

Advice from Dr. Oleg Korzhikov

"Many patients ask me why it is important to start treatment as early as possible. The fact is that timely therapy helps prevent irreversible changes in target organs. Parents often ask about diet - I recommend limiting sodium intake and regularly monitoring potassium levels. Many want to know whether they can play sports - if the condition is stable, this is not only possible, but also necessary for overall health."